These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 30022999)
1. RHBDF2-Regulated Growth Factor Signaling in a Rare Human Disease, Tylosis With Esophageal Cancer: What Can We Learn From Murine Models? Hosur V; Farley ML; Low BE; Burzenski LM; Shultz LD; Wiles MV Front Genet; 2018; 9():233. PubMed ID: 30022999 [TBL] [Abstract][Full Text] [Related]
2. RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. Blaydon DC; Etheridge SL; Risk JM; Hennies HC; Gay LJ; Carroll R; Plagnol V; McRonald FE; Stevens HP; Spurr NK; Bishop DT; Ellis A; Jankowski J; Field JK; Leigh IM; South AP; Kelsell DP Am J Hum Genet; 2012 Feb; 90(2):340-6. PubMed ID: 22265016 [TBL] [Abstract][Full Text] [Related]
3. Genetic deletion of amphiregulin restores the normal skin phenotype in a mouse model of the human skin disease tylosis. Hosur V; Low BE; Shultz LD; Wiles MV Biol Open; 2017 Aug; 6(8):1174-1179. PubMed ID: 28655741 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the function of ADAM17 in iRhom2 curly-bare and tylosis with esophageal cancer mutant mice. Rabinowitsch AI; Maretzky T; Weskamp G; Haxaire C; Tueshaus J; Lichtenthaler SF; Monette S; Blobel CP J Cell Sci; 2023 Jul; 136(13):. PubMed ID: 37282854 [TBL] [Abstract][Full Text] [Related]
5. Analysis of a Finnish family confirms RHBDF2 mutations as the underlying factor in tylosis with esophageal cancer. Saarinen S; Vahteristo P; Lehtonen R; Aittomäki K; Launonen V; Kiviluoto T; Aaltonen LA Fam Cancer; 2012 Sep; 11(3):525-8. PubMed ID: 22638770 [TBL] [Abstract][Full Text] [Related]
6. Tissue-specific role of RHBDF2 in cutaneous wound healing and hyperproliferative skin disease. Hosur V; Lyons BL; Burzenski LM; Shultz LD BMC Res Notes; 2017 Nov; 10(1):573. PubMed ID: 29116018 [TBL] [Abstract][Full Text] [Related]
7. ADAM17 is essential for ectodomain shedding of the EGF-receptor ligand amphiregulin. Hosur V; Farley ML; Burzenski LM; Shultz LD; Wiles MV FEBS Open Bio; 2018 Apr; 8(4):702-710. PubMed ID: 29632822 [TBL] [Abstract][Full Text] [Related]
9. Investigating iRHOM2-Associated Transcriptional Changes in Tylosis With Esophageal Cancer. Murtough S; Babu D; Webb CM; Louis Dit Picard H; McGinty LA; Chao-Chu J; Pink R; Silver AR; Smart HL; Field JK; Woodland P; Risk JM; Blaydon DC; Pennington DJ; Kelsell DP Gastro Hep Adv; 2024; 3(3):385-395. PubMed ID: 39131151 [TBL] [Abstract][Full Text] [Related]
10. Pathological mutations reveal the key role of the cytosolic iRhom2 N-terminus for phosphorylation-independent 14-3-3 interaction and ADAM17 binding, stability, and activity. Bläsius K; Ludwig L; Knapp S; Flaßhove C; Sonnabend F; Keller D; Tacken N; Gao X; Kahveci-Türköz S; Grannemann C; Babendreyer A; Adrain C; Huth S; Baron JM; Ludwig A; Düsterhöft S Cell Mol Life Sci; 2024 Feb; 81(1):102. PubMed ID: 38409522 [TBL] [Abstract][Full Text] [Related]
11. Loss of RHBDF2 results in an early-onset spontaneous murine colitis. Geesala R; Schanz W; Biggs M; Dixit G; Skurski J; Gurung P; Meyerholz DK; Elliott D; Issuree PD; Maretzky T J Leukoc Biol; 2019 Apr; 105(4):767-781. PubMed ID: 30694569 [TBL] [Abstract][Full Text] [Related]
12. iRhoms; Its Functions and Essential Roles. Lee MY; Nam KH; Choi KC Biomol Ther (Seoul); 2016 Mar; 24(2):109-14. PubMed ID: 26869525 [TBL] [Abstract][Full Text] [Related]
13. Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25. Risk JM; Ruhrberg C; Hennies H; Mills HS; Di Colandrea T; Evans KE; Ellis A; Watt FM; Bishop DT; Spurr NK; Stevens HP; Leigh IM; Reis A; Kelsell DP; Field JK Genomics; 1999 Jul; 59(2):234-42. PubMed ID: 10409435 [TBL] [Abstract][Full Text] [Related]
14. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells. Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866 [TBL] [Abstract][Full Text] [Related]
15. Genetic interaction implicates iRhom2 in the regulation of EGF receptor signalling in mice. Siggs OM; Grieve A; Xu H; Bambrough P; Christova Y; Freeman M Biol Open; 2014 Nov; 3(12):1151-7. PubMed ID: 25395669 [TBL] [Abstract][Full Text] [Related]
16. Tylosis associated with squamous cell carcinoma of the oesophagus (TOC): Report of an African family with a novel RHBDF2 variant. Mokoena T; Smit JGM; Karusseit VO; Dorfling CM; van Rensburg EJ Clin Genet; 2018 May; 93(5):1114-1116. PubMed ID: 29372562 [No Abstract] [Full Text] [Related]
17. Investigating isoform switching in Masood M; Masood MBE; Us Subah N; Shabbir M; Paracha RZ; Rafiq M PeerJ; 2022; 10():e14124. PubMed ID: 36452073 [TBL] [Abstract][Full Text] [Related]
18. Amphiregulin potentiates airway inflammation and mucus hypersecretion induced by urban particulate matter via the EGFR-PI3Kα-AKT/ERK pathway. Wang J; Zhu M; Wang L; Chen C; Song Y Cell Signal; 2019 Jan; 53():122-131. PubMed ID: 30291869 [TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor (EGF) receptor-ligand based molecular staging predicts prognosis in head and neck squamous cell carcinoma partly due to deregulated EGF- induced amphiregulin expression. Gao J; Ulekleiv CH; Halstensen TS J Exp Clin Cancer Res; 2016 Sep; 35(1):151. PubMed ID: 27669890 [TBL] [Abstract][Full Text] [Related]